Progression/relapse · Patients with untreated Hodgkin lymphoma (early stages)
Chemotherapy plus involved‐field radiation showed no clear difference in progression/relapse compared with same chemotherapy plus extended‐field radiation (high certainty).
1 finding from 1 review
Secondary malignant neoplasms · Patients with untreated Hodgkin lymphoma (early stages)
Chemotherapy plus lower‐dose radiation showed no clear difference in secondary malignant neoplasms compared with same chemotherapy plus higher‐dose radiation (low certainty).
1 finding from 1 review
Death · Patients with untreated Hodgkin lymphoma (early stages)
Chemotherapy plus lower‐dose radiation showed no clear difference in death compared with same chemotherapy plus higher‐dose radiation (high certainty).
1 finding from 1 review
Progression/relapse · Patients with untreated Hodgkin lymphoma (early stages)
Chemotherapy plus lower‐dose radiation showed no clear difference in progression/relapse compared with same chemotherapy plus higher‐dose radiation (high certainty).
1 finding from 1 review
Intervention not reported
Comparisons** · Women in assisted reproductive technology cycles (ART) receiving human pre‐implantation embryos in either early (cleavage stage transfer)…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Late embryo transfer ‐ GM501 (specific) versus Sydney IVF (other) · Women in assisted reproductive technology cycles (ART) receiving human pre‐implantation embryos in either early (cleavage stage transfer)…
It is very uncertain whether the intervention changes late embryo transfer ‐ GM501 (specific) versus Sydney IVF (other) (very low certainty).
1 finding from 1 review
Intervention not reported
Late embryo transfer ‐ G2 (specific) versus Universal IVF (other) · Women in assisted reproductive technology cycles (ART) receiving human pre‐implantation embryos in either early (cleavage stage transfer)…
It is very uncertain whether the intervention changes late embryo transfer ‐ G2 (specific) versus Universal IVF (other) (very low certainty).
1 finding from 1 review
Intervention not reported
Late embryo transfer ‐ ECM/Multiblast (specific) versus Global (other) · Women in assisted reproductive technology cycles (ART) receiving human pre‐implantation embryos in either early (cleavage stage transfer)…
It is very uncertain whether the intervention changes late embryo transfer ‐ ECM/Multiblast (specific) versus Global (other) (very low certainty).
1 finding from 1 review
Intervention not reported
Ascitis · Patients with dengue infection at an early stage
It is very uncertain whether the intervention changes ascitis (very low certainty).
1 finding from 1 review
Intervention not reported
ICU admission · Patients with dengue infection at an early stage
It is very uncertain whether the intervention changes ICU admission (very low certainty).
1 finding from 1 review
Intervention not reported
Death · Patients with dengue infection at an early stage
1 finding from 1 review
Intervention not reported
Severe dengue: shock · Patients with dengue infection at an early stage
It is very uncertain whether the intervention changes severe dengue: shock (very low certainty).
1 finding from 1 review
Intervention not reported
Severe dengue: severe bleeding · Patients with dengue infection at an early stage
It is very uncertain whether the intervention changes severe dengue: severe bleeding (very low certainty).
1 finding from 1 review
Intervention not reported
Severe thrombocytopaenia11 · Patients with dengue infection at an early stage
It is very uncertain whether the intervention changes severe thrombocytopaenia11 (very low certainty).
1 finding from 1 review
Overall survival · 578 patients with early HCC
1 finding from 1 review
Local progression · 1088 patients with early HCC
1 finding from 1 review
Rate of complications · 1088 patients with early HCC
1 finding from 1 review
Length of hospital stay · 1088 patients with early HCC
1 finding from 1 review
2‐year survival‐ · 578 patients with early HCC
1 finding from 1 review
Event‐free survival · 578 patients with early HCC
1 finding from 1 review